1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

Global Heparin Market 2016-2020

  • March 2016
  • 73 pages
  • Infiniti Research Limited
Report ID: 1045447

Summary

Table of Contents

Search Inside

About Heparin

Heparin, a disaccharide anticoagulant or blood thinner, prevents the formation of blood clots. It is produced in the body by basophils and mast cells. It is stored within mast cells and secreted at the injury site. Though it has no effect on already formed clots, it enables the body's natural clot lysis mechanisms to dissolve clots. It can also be taken from outside as a drug. Heparin can be derived from natural sources such as pig intestine and bovine lungs.
Heparin is divided into two types based on the fractionation process. Both types have medical use, with the selection done based on preference for a particular condition.
- UFH: It is directly obtained from natural sources, without undergoing any fractionation.
- LMWH: It is derived by depolymerizing UFH. The pharmacodynamics properties of LMWH are more predictable when compared to UFH.
Apart from these, another category of molecules, ULMWH are available. They are structurally related to LMWHs, but differ in the composition of monosaccharides and oligosaccharides. Therefore, they have different average molecular weights from LMWH.

Technavio’s analysts forecast the global heparin market to grow at a CAGR of 4.74% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global heparin market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generics used to treat disorders.


The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Heparin Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendorsoperating in this market.

Key vendors
- GlaxoSmithKline plc (GSK)
- Leo Pharma A/S
- Pfizer Inc.
- Sanofi


Other prominent vendors
- Alchemi
- Baxter
- BMS
- Boehringer Ingelheim
- Celgene
- Cosmo Pharmaceuticals
- Dr.Reddy's Laboratories
- Eisai
- Fresenius
- GSK
- Hospira
- Laboratorios Rovi Pharmaceuticals
- Lee's Pharmaceutical
- Momenta Pharmaceuticals
- Mylan
- Novartis
- Ockham Biotech
- Perospher
- PolyMedix
- Portola Pharmaceutical
- ProStrakan Group
- Sagent Pharmaceticals
- Sigma Tau Pharmaceuticals
- UCB
- Urigen Pharmaceuticals

Market driver
- Growing prevalence of diseases
- For a full, detailed list, view our report

Market challenge
- Extensive use of generic products due to patent expirations
- For a full, detailed list, view our report

Market trend
- Expected exploitation of new therapeutic use
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Amrita helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Epiomic Epidemiology Series: Sickle Cell Disease Forecast in 10 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • July 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Sickle Cell Disease in 10 Major Markets Sickle cell disease (SCD) is a term comprising clinically relevant haemoglobinopathies caused ...

Global Genetic Testing Market

  • $ 4250
  • Industry report
  • July 2017
  • by Mordor Intelligence LLP

The global genetic testing market accounted for USD 3.8 Billion in 2015 and is estimated to reach USD 4.23 billion in 2016. Growing at a moderately high CAGR of 9.7%, the market value is expected to reach ...

Blood Disease Drugs Markets in China

  • $ 4000
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

China’s demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.